Back to Search
GARY CLAYMAN, M.D., DMD
M.D., DMD
Surgery Physician
NPI: 1902905219IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology Physician
Otolaryngology
Code: 207Y00000X
H5856(TX)
Surgery PhysicianPrimary
Surgery
Code: 208600000X
ME125739(FL)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
NORTHEASTERN OHIO UNIVERSITY COLLEGE OF MEDICINE
Class of 1986
Research & Publications (20)
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
PMID 19360746·Head Neck·2009
8-other
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
PMID 19200582·Hum Pathol·2009
8-other
Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
PMID 19095376·Int J Radiat Oncol Biol Phys·2009
8-other
Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
PMID 19176870·Exp Biol Med (Maywood)·2009
8-other
Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.
PMID 19380355·Arch Otolaryngol Head Neck Surg·2009
7-preclinical
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
PMID 19355831·Thyroid·2009
5-case
High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.
PMID 19147753·Clin Cancer Res·2009
8-other
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
PMID 19107951·Head Neck·2009
8-other
An orthotopic model of papillary thyroid carcinoma in athymic nude mice.
PMID 18283163·Arch Otolaryngol Head Neck Surg·2008
7-preclinical
Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.
PMID 18676765·Clin Cancer Res·2008
7-preclinical
Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
PMID 17949783·Hum Pathol·2008
8-other
LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulation.
PMID 18004979·DNA Cell Biol·2008
4-observational
Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
PMID 17989726·J Invest Dermatol·2008
8-other
Parotid gland oncocytosis: CT findings with histopathologic correlation.
PMID 18272563·AJNR Am J Neuroradiol·2008
5-case
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
PMID 18213725·Head Neck·2008
8-other
Predictors of level V metastasis in well-differentiated thyroid cancer.
PMID 18704973·Head Neck·2008
8-other
Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma.
PMID 18327775·Head Neck·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2400 CYPRESS GLEN DR
WESLEY CHAPEL, FL 33544 - Phone
- (813) 940-3130
Quick Facts
- NPI
- 1902905219
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile